What they were paid
Verastem Director Compensation Table · all 2 fiscal years held| Fiscal year | Cash fees | Stock awards | Option awards | Other | Total |
|---|---|---|---|---|---|
| FY2025 | $60,000 | $62,331 | $75,662 | $0 | $197,993 |
| FY2024 | $60,000 | $27,249 | $32,926 | $0 | $120,175 |
Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: Verastem, Inc. DEF 14A filed April 9, 2026, accession 0001104659-26-041506, and prior-year filings. Open the filing on EDGAR.
Committees
FY2025 · as the proxy prints themAudit · Nominating/Governance · Commercialization
The rest of the Verastem board
FY2025 · as the company reported each| Director | Role | FY2025 total |
|---|---|---|
| Anil Kapur | Independent Director | $209,993 |
| Brian Stuglik | Director | $202,993 |
| Daniel Paterson | Director | $0 |
| Eric Rowinsky, M.D | Independent Director | $214,993 |
| John Johnson | Lead Independent Director | $199,993 |
| Michael Kauffman, M.D., Ph.D | Director | $242,993 |
| Michael P. Bailey | Independent Director | — |
| Michelle Robertson | Independent Director | $202,993 |
| Paul Bunn, M.D | Independent Director | $192,993 |
The full Verastem compensation record
free company briefThis page is one director within Verastem's record. The company brief lists every named executive and director, each linking to their own page.
Velarion Pro: every company page, peer tools and exports, one seat